Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Neuromolecular Medicine|December 1, 2009
Metal ion physiopathology in neurodegenerative disordersSilvia Bolognin, Luigi Messori, Paolo ZattaJournal of Alzheimer'S Disease : JAD|June 5, 2009
Interaction between Alzheimer's amyloid-beta and amyloid-beta-metal complexes with cell membranesMario Suwalsky, Silvia Bolognin, Paolo ZattaJournal of Alzheimer'S Disease : JAD|March 1, 2014
Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approachesSilvia Bolognin, Bruno Cozzi, Pamela Zambenedetti, et al.Neurobiology of Aging|April 8, 2014
Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compoundSilvia Bolognin, Mario Buffelli, Jukka Puoliväli, et al.Medicinal Research Reviews|January 30, 2009
Chelation therapy for neurodegenerative diseasesSilvia Bolognin, Denise Drago, Luigi Messori, et al.Molecular Neurobiology|January 24, 2014
The potential role of rho GTPases in Alzheimer's disease pathogenesisSilvia Bolognin, Erika Lorenzetto, Giovanni Diana, et al.Trends in Pharmacological Sciences|June 23, 2009
Alzheimer's disease, metal ions and metal homeostatic therapyPaolo Zatta, Denise Drago, Silvia Bolognin, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic CompoundSabiha Khatoon, Sonia Chalbot, Silvia Bolognin, et al.Neurochemistry International|February 19, 2013
β-Amyloid-aluminum complex alters cytoskeletal stability and increases ROS production in cortical neuronsSilvia Bolognin, Paolo Zatta, Erika Lorenzetto, et al.Biophysical Chemistry|March 29, 2008
Human cells and cell membrane molecular models are affected in vitro by chlorpromazineMario Suwalsky, Fernando Villena, Carlos P Sotomayor, et al.Pageof 6